⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL49898 | 0.90 | — | — | |
| SCHEMBL6014655 | 0.88 | KDM1A (0.39) | — | |
| SCHEMBL6014396 | 0.88 | — | — | |
| SCHEMBL2486743 | 0.88 | — | — | |
| SCHEMBL15904034 | 0.88 | — | — | |
| SCHEMBL6014401 | 0.88 | — | — | |
| SCHEMBL14210854 | 0.88 | KDM1A (0.39) | — | |
| SCHEMBL6014657 | 0.88 | KDM1A (0.39) | — | |
| SCHEMBL18571425 | 0.88 | KDM1A (0.39) | — | |
| SCHEMBL29002299 | 0.88 | KDM1A (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118119596-A | Preparation method of drug intermediate | 浙江华海药业股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| EP-4370206-A1 | ESTERS OF 7-COOH CBD DERIVATIVES AND THEIR USE AS PREVENTION, PROPHYLAXIS OF PROGRESSION, AND/OR TREATMENT OF NEUROGENERATIVE DISEASES | Receptorpharma Inc S-Corp (US) | 2024-05-22 | — | — | EP | claimed |
| WO-2023098640-A1 | PREPARATION METHOD FOR DRUG INTERMEDIATE | 浙江华海药业股份有限公司 | 2023-06-08 | — | — | WO | claimed |
| WO-2023285072-A1 | ESTERS OF 7-COOH CBD DERIVATIVES AND THEIR USE AS PREVENTION, PROPHYLAXIS OF PROGRESSION, AND/OR TREATMENT OF NEUROGENERATIVE DISEASES. | RECEPTORPHARMA INC S-CORP (US) | 2023-01-19 | — | — | WO | claimed |
| US-11149045-B2 | Raw material for vapor deposition including organoplatinum compound and vapor deposition method using the raw material for vapor deposition | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2021-10-19 | — | — | US | claimed |
| US-20200148713-A1 | RAW MATERIAL FOR VAPOR DEPOSITION INCLUDING ORGANOPLATINUM COMPOUND AND VAPOR DEPOSITION METHOD USING THE RAW MATERIAL FOR VAPOR DEPOSITION | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2020-05-14 | — | — | US | claimed |
| US-7666976-B2 | Polyamides | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-23 | — | — | US | claimed |
| EP-1625173-B1 | POLYAMIDES | BASF AG (DE) | 2007-08-15 | — | — | EP | claimed |
| US-20060223974-A1 | main chain contains a chemically bound amine selected from 2-methyl-1,5-diaminopentane and 1-amino-2-R-cyclopent-1-ene, where R is a functional group capable of combining with an amino group to form an amide group; for fibers, films and moldings | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-05 | — | — | US | claimed |
| EP-1625173-A1 | POLYAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-15 | — | — | EP | claimed |
| WO-2005091840-A2 | COMPATIBILIZERS FOR FLUOROPOLYMERS AND POLYOLEFINS; BLENDS THEREOF | TEKNOR APEX COMPANY (US) | 2005-10-06 | — | — | WO | claimed |
| US-20040261198-A1 | Restructuring and finishing of keratin fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-12-30 | — | — | US | claimed |
| WO-2004101648-A1 | POLYAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-25 | — | — | WO | claimed |
| EP-1455736-A1 | RESTRUCTURING AND FINISHING OF KERATIN FIBERS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-09-15 | — | — | EP | claimed |
| WO-2003053375-A1 | RESTRUCTURING AND FINISHING OF KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-07-03 | — | — | WO | claimed |
| EP-0128006-A2 | A soil-disease-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-12-12 | — | — | EP | claimed |
| JP-1042499-A | — | — | None | — | — | JP | disclosed |
| JP-1308259-A | — | — | None | — | — | JP | disclosed |
| US-4163024-A | NICKEL CATALYST | STUDIENGESELLSCHAFT KOHLE MBH. (DE) | 1979-07-31 | — | — | US | disclosed |
| US-3969365-A | ANTIINFLAMMATORY, HYPOGLYCEMIC | E. R. SQUIBB & SONS, INC. (US) | 1976-07-13 | — | — | US | disclosed |